Biotech Values

[bridgeofsighs]

When Byetta first hit the market I was told by an endocrinologist that Byetta was a life changing drug he had patients that were taking cholesterol medicine high blood pressure medicine were overweight and of course had type 2 diabetes after starting some of these patients on Byetta they lost weight had control of their diabetes and were able to come off all other medications. The momentum for Byetta was in place the company had to strike when the iron was hot then the shortages happened and the wheels came off. At that point I think Ginger Graham was looked at as the CEO that could only take them through the development stage and was not the right person to run a large commercial operation I thought she was a good CEO and I am not impressed with Bradbury. I don't think AMLN did enough to combat Januvia which was being marketed to general practitioners as the pill form of Byetta endocrinologist new better and continued to prescribe Byetta. The bottom line to me is Byetta LAR still has a chance to be a huge blockbuster even with its HUGE needle gauge. ;)